Archives : August 2016

Free Online Course on Parkinson’s to Start on October 17- Sign Up Now!


FutureLearn is offering a free online course by the University of Birmingham, three hours per week for three weeks. It’s the perfect resource to learn all the basics about Parkinson’s.

“This free online course is aimed at anyone who wants to find out the fundamentals of Parkinson’s disease. We will look at how Parkinson’s disease affects people; what causes it; what we can do to try to ameliorate the symptoms of Parkinson’s; and what we don’t yet know about it.”

Click here to learn more and sign up! 

Merger: National Parkinson’s Foundation and Parkinson’s Disease Foundation to Join Forces


Big news! We are excited to announce the new Parkinson’s Foundation, an organization formed through the merger of the Parkinson’s Disease Foundation and National Parkinson Foundation. Both PDF and NPF are excited to work together toward a world without Parkinson’s. “The Parkinson’s Foundation will be greater than the sum of our individual parts … coming together has redoubled our shared spirit of focus and purpose.”

“This merger is about the future and we are thrilled to have it completed,” said John Kozyak, Board Chair of the Parkinson’s Foundation. “Millions of people worldwide are living with Parkinson’s. We owe it to them to move the science and care forward and the merger allows us to do just that even better. We are driven by the perspective, needs and priorities of people living with the disease and, together, we will be a formidable and effective force in the fight against Parkinson’s.”

Read on here:

Congratulations Dr. Rosalind Roberts!


The Montreal Neurological Institute and McGill University have received funding for a postdoctoral fellowship from the Parkinson’s Disease Foundation to further our knowledge of the disease, with the goal of developing better treatments.

Dr. Rosalind Roberts will investigate the function of mitochondrial derived vesicles (MDVs) in neurons and their role in Parkinson’s disease.

“MDVs are important for removing damaged components from mitochondria to ensure they keep working properly,” says Roberts. “However, the exact mechanisms at many stages of this pathway are yet to be discovered, such as the machinery for their biogenesis and transport, and how cargo proteins are selected. There’s still a lot to find out about them from a basic science perspective, which is exciting.”

Dr. Roberts earned her PhD degree from Oxford and her BSc from Cardiff University. She will be working at the lab of Dr. Edward Fon, Director of the Quebec Parkinson’s Network.

“Rosalind brings experience in Parkinson’s disease research from Oxford and she is an extremely thoughtful and enthusiastic scientist,” says Fon. “Mitochondrial vesicles may help discover how Parkin and PINK1, two PD genes, keep mitochondria healthy in neurons. This may point us toward new therapeutic targets for PD.”

The Parkinson’s Disease Foundation® (PDF®) is a leading national presence in Parkinson’s disease research, education and public advocacy.

Stem Cells May Be the Key To a Deeper Understanding of Parkinson’s, Along with New Treatments


Advances in technology are allowing scientists to engineer dopamine neurons, which degenerate and die in Parkinson’s disease, from skin and blood cells. Researchers are attempting to use these neurons to replace what is lost in Parkinson’s and restore motor function. In addition, the cells can serve as research tools for exploration into the disease process and impact of therapeutic intervention.

“The complexity and mystery of brain diseases make them incredibly difficult to understand and to treat,” says MJFF CEO Todd Sherer, PhD. “Stem cell technologies may offer a more sophisticated dopamine replacement approach and provide the opportunity to study the influence of disease and of interventions on these vulnerable cells.”

Read on at


Montreal Researchers Discover that Parkinson’s Could Be Linked to Autoimmune Diseases


Scientists at the Montreal Neurological Institute (McGill) and University of Montreal have discovered a new link between Parkinson’s Disease and autoimmune diseases. Dr. Heidi McBride and Dr. Michel Desjardins are thrilled about this new way to approach this difficult neurodegenerative disease and find new paths for treatment.

To learn more, see and


Study Testing a New Medication to Slow Parkinson’s Progression is Now Recruiting around The United States


A compound that researchers believe may lower the risk of Parkinson’s disease (PD) and slow progression is now in the final stage of clinical testing. The study was funded by the Michael J Fox Foundation for Parkinson’s Research.

Read more about this new advance here:

The Parkinson’s Journey: Sign Up to Raise Money for Parkinson’s This September


Parkinson’s Journey is a walk taking place on Saturday, September 10th or Sunday, September 11th, 2016 in 11 cities across Quebec to support people living with Parkinson’s disease. There are different ways to participate: you can register as a single participant, as a team or join a team.

You can also show your support by making a donation to encourage a participant, a team or an event in particular.

To read more, sign up, or donate, click here: